Search research articles
Contact Us
Filters
Showing results (351-360 of 369) with videos related to
Page
of 37
Sort By:
The Pediatric Infectious Disease Journal
|
March 19, 2019
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies
Gabriela Patten, Michael Schomaker, Mary-Ann Davies, et al.
Epidemiology (Cambridge, Mass.)
|
October 20, 2015
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis
Michael Schomaker, Mary-Ann Davies, Karen Malateste, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2013
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
Joseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
The New England Journal of Medicine
|
November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples
Rochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
The Journal of Infection
|
May 19, 2022
Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis
Ashar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Journal of Infectious Diseases
|
June 21, 2019
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial
Christina Ekenberg, Man-Hung Tang, Adrian G Zucco, et al.
The Lancet. Respiratory Medicine
|
October 25, 2016
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial
Ken M Kunisaki, Dennis E Niewoehner, Gary Collins, et al.
Plos Medicine
|
September 7, 2021
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study
Andrew F Auld, Andrew D Kerkhoff, Yasmeen Hanifa, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
Krishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
The Lancet. Global Health
|
November 14, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
Krishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 369) with videos related to
Sort By:
Page
of 37
The Pediatric Infectious Disease Journal
|
March 19, 2019
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies
Gabriela Patten, Michael Schomaker, Mary-Ann Davies, et al.
Epidemiology (Cambridge, Mass.)
|
October 20, 2015
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis
Michael Schomaker, Mary-Ann Davies, Karen Malateste, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2013
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
Joseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
The New England Journal of Medicine
|
November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples
Rochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
The Journal of Infection
|
May 19, 2022
Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis
Ashar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Journal of Infectious Diseases
|
June 21, 2019
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial
Christina Ekenberg, Man-Hung Tang, Adrian G Zucco, et al.
The Lancet. Respiratory Medicine
|
October 25, 2016
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial
Ken M Kunisaki, Dennis E Niewoehner, Gary Collins, et al.
Plos Medicine
|
September 7, 2021
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study
Andrew F Auld, Andrew D Kerkhoff, Yasmeen Hanifa, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
Krishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
The Lancet. Global Health
|
November 14, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
Krishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Page
of 37